Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Recent findings from University of Texas highlight research in cancer vaccines
September 10th, 2008
According to recent research from the United States, "Heat shock proteins (HSPs) are highly conserved stress-induced proteins which function as chaperones for trafficking peptides inside different cellular compartments and delivering peptides. Tumor-derived HSP-peptide complexes (HSPPCs) can be used for vaccination against malignancies." "An HSP-based vaccine is a personalized vaccine that carries the fingerprint of a given tumor, circumventing the need for identifying tumor antigens for each individual cancer. Vitespen (Oncophage (R), formerly HSPPC-96) is a novel vaccine preparation with a promising role in cancer management. This vaccine has essentially no toxicity...
Source: Vaccine Weekly (2008-09-10)
|
